Vaxelis a new pediatric vaccine manufactured by the Sanofi a global biopharmaceutical company, the vaccine is invented in order to immunize children against six various diseases. The vaccine was tested on various scales before being approved and recently received an approval from the U.S. Food and Drug Administration on the basis of the trials that were held in the French pharmaceutical lab announcement on Wednesday. The vaccine was produced in the partnership with the Merck, which is another pharmaceutical company well-established globally. Vaxelis is produced along with the design that will be effective for children among the age group from 6 weeks to 4 years old in order to keep them away from illness or disorders like tetanus, poliomyelitis, diphtheria, pertussis, hepatitis B as well as invasive disease caused because of the haemophilus influenza type B. Merck and Sanofi the two mega pharmaceutical companies at present are working together in order to produce and distribute Vaxelis at a large-scale level globally and establish a well spread market till the year 2020 and over.